Check each drug's suppliers before Lonza's planned takeover
- For
- Procurement, quality and supply-planning teams at drug companies using both Lonza and Merck KGaA's US contract manufacturing operations.
- Where
- US manufacturing sites. Product example: Madison, Wisconsin, and Visp, Switzerland, in a Korean-market document.
- What it means
Lonza plans to buy five US drug-making sites from Merck KGaA.
- Why it matters
Two sites listed in a dated Polivy manufacturing record could share a parent after closing.
- What to do
Check each product's current sites, roles, contracts and approved alternatives before the next 2027 sourcing decision.
- What we don't know
The record does not prove today's supply, interchangeable backups, a shortage or changed prices. The deal has not closed.
- Profitable
- Unassessed/1,000Not scored
- Commercial potential · Higher is better
- Early
- Unassessed% awareNot scored
- Stated audience awareness · Lower is earlier
- Useful & actionable
- Unassessed/1,000Not scored
- Practical value · Higher is better
First published